Cloder

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cloder

Property Description
Active ingredient Chlorhexidine Gluconate
Form Aqueous Solution, Oral Rinse, Topical Liquid
Pharmacological class Antiseptic and Disinfectant (Broad-spectrum Antimicrobial)
General purpose Local control of microbial load on surfaces and tissue
Origin Synthetic (Biguanide derivative)

What Type of Medicine is Cloder?

Cloder is a pharmaceutical preparation containing the active ingredient, Chlorhexidine Gluconate, an antiseptic and disinfectant agent. This compound is a synthetic biguanide derivative, utilized for localized microbial control, distinguishing its function from systemic antibiotics. The preparation is most frequently encountered as an aqueous solution or oral rinse, designed for direct topical or oromucosal application, characterizing its role in managing surface hygiene in healthcare and personal care settings.

Composition and Purpose of the Active Ingredient

The therapeutic action of Cloder is centered on the chemical structure of Chlorhexidine Gluconate, a cationic (positively charged) molecule. This property is its chief differentiating feature, as it enables the binding of the agent to the negatively charged cell walls of microorganisms, causing membrane disruption. This interaction results in the ability of the agent to remain active on treated surfaces for extended periods, a property known as substantivity.

This prolonged action, which helps to inhibit the re-establishment of pathogens, is utilized for managing the local microbial load. A common, neutral use scenario is the application of a chlorhexidine gluconate oral rinse to reduce bacteria in the mouth. The general purpose of this sustained action is to provide a non-systemic method for local decontamination and tissue hygiene management.

What side effects are possible with Cloder?

The safety profile of Chlorhexidine Gluconate (Cloder) is officially structured by frequency classifications and System-Organ Classes, as documented in regulatory labeling.

Adverse Reaction Scope

Classification & System Officially Documented Effects
Very Common (ge 1/10) Taste disturbance (dysgeusia), coating of the tongue.
Common (ge 1/100 to <1/10) Extrinsic dental staining (discoloration of teeth and tongue), increase in supragingival calculus formation (tartar).
Rare / Very Rare Hypersensitivity reactions, Anaphylactic reaction.
System-Organ Classes Gastrointestinal Disorders (oral irritation, parotid gland swelling) and Immune System Disorders (allergic reactions).

The most serious documented safety concern is the potential for anaphylaxis, which is classified as a rare but severe allergic reaction and may occur within minutes of exposure. The label includes mandatory restrictions stating the product is for external/topical use (or topical oral use for the rinse) only and must avoid contact with sensitive tissues such as the eyes, middle ear, and central nervous tissues. Safety notes also state that dental staining is more probable with prolonged use, while the change in taste is often a transient effect.

For specific patient groups, regulatory documents caution that use in children under 12 years of age is generally advised only under the direction of a healthcare professional. The official safety information structures the risk by separating the anticipated local effects from the critical, rare risk of a systemic immune response, defining the boundaries for the product's safe use.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Cloder overdose addresses two primary scenarios: severe hypersensitivity reactions and accidental ingestion of the liquid formulation. All statements regarding required emergency actions are strictly based on government-authorized prescribing information.

When to Seek Immediate Medical Help

Emergency medical care is required immediately if the user experiences any signs of a serious allergic reaction, as these can progress rapidly and include fatal anaphylaxis and shock. Symptoms requiring urgent action are difficulty breathing, wheezing, swelling of the face, or a rapidly spreading severe rash or hives. Regulatory authorities mandate that the product must be stopped and immediate medical attention or 911 must be sought for these manifestations.

Accidental Ingestion

Accidental swallowing of the solution may cause gastric distress and nausea; systemic toxicity is unlikely due to the drug's poor oral absorption. However, ingestion of alcohol-containing formulations, particularly by small children, poses a risk of alcohol intoxication. Medical attention must be sought immediately if a small child has ingested more than four ounces of the oral rinse or shows signs of intoxication. Management for ingestion cases is symptomatic and supportive, sometimes involving gastric lavage, as no specific antidote is known for the active ingredient.

Therapeutic Uses of Cloder

Main Uses and Benefits of Cloder

Cloder is a topical corticosteroid medication used to manage various inflammatory and pruritic (itchy) skin conditions. It belongs to a class of potent medications designed to reduce the physical symptoms associated with skin irritation and immune-mediated responses.

Therapeutic Applications

The primary use of Cloder is to alleviate the symptoms of non-infectious inflammatory dermatoses. These conditions often manifest as redness, swelling, and persistent itching. By targeting the underlying inflammatory process, the medication helps to stabilize the skin surface and provide relief from physical discomfort.

Specific conditions where Cloder may be utilized include:

  • Psoriasis: To manage plaque-type psoriasis by reducing the thickening of the skin and the formation of scales.
  • Eczema and Dermatitis: To treat various forms of eczema, including atopic and contact dermatitis, by calming the skin’s reaction to irritants or allergens.
  • Lichen Planus: To address the inflammatory patches and lesions associated with this chronic condition.
  • Other Corticosteroid-Responsive Dermatoses: To treat less common skin disorders that respond to steroid-based intervention.

Clinical Benefits

The benefits of Cloder center on its ability to improve the quality of life for individuals with chronic or acute skin conditions. Its application serves several key functions:

  • Reduction of Inflammation: It works to decrease vasodilation and the release of inflammatory mediators, which reduces visible redness and swelling.
  • Itch Relief: By suppressing the immune response in the localized area, it significantly diminishes the urge to scratch, which prevents further damage to the skin barrier.
  • Symptom Management: Regular application according to clinical guidance can lead to the clearing of skin lesions and a return to a more normal skin appearance.
  • Rapid Action: As a potent corticosteroid, it is designed to provide relatively quick symptomatic relief compared to milder topical treatments.

Regulatory References

  1. NIH DailyMed Overview

Eligibility and Restrictions for Use

Who can and cannot use Cloder?

Official regulatory documents define the population eligibility for this oral rinse based on age, physiological status, and contraindications.


Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults (18 years and older) are the established population for whom the clinical effectiveness and safety have been determined.
Populations for whom use is contraindicated Persons with a known hypersensitivity or allergy to Chlorhexidine Gluconate or any other ingredient in the formulation.
Age-related eligibility rules Pediatric Use: Safety and effectiveness are not established in children under the age of 18. Geriatric Use: Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently.
Pregnancy and lactation eligibility status Pregnancy: Use should occur only if clearly needed due to a lack of adequate human studies. Lactation: Caution should be exercised as it is not known if the drug is excreted in human milk.
Eligibility-related restrictions Caution is advised for patients with coexisting periodontitis or Acute Necrotizing Ulcerative Gingivitis (ANUG), as the effect on these conditions has not been determined or tested.

Connection to the overall eligibility profile

The eligibility profile establishes a clear prohibition for individuals with a history of hypersensitivity to the drug. Beyond this absolute contraindication, the established use of the medicine is limited to adults. Official labeling further classifies use during pregnancy, lactation, and in patients with coexisting gum conditions under restricted or conditional terms, reflecting the boundaries of established clinical data.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Cloder is structured primarily around local administration constraints, as regulatory documents specify no known systemic pharmacokinetic interactions with other medicines. This determination is consistent with the minimal systemic absorption of the active ingredient, resulting in an absence of documented CYP-mediated or transporter-based interactions.

The most relevant documented interaction is a local pharmacodynamic antagonism with anionic agents, such as Sodium Lauryl Sulfate (SLS), which is commonly found in dentifrice. This chemical incompatibility causes the neutralization and inactivation of the cationic Chlorhexidine, thereby reducing its intended effect. This local interaction is classified as clinically significant and requires specific procedural constraints.

To maintain efficacy, the label imposes a strict timing separation requirement: administration must be separated from toothbrushing with anionic toothpaste by at least 30 minutes. Furthermore, the regulatory basis specifies that patients must not rinse with water or use other mouthwashes immediately following application. The interaction scope also addresses formulation components: alcohol-containing versions are subject to restriction or contraindication in patients with a history of alcoholism. A required waiting period for food and beverages is also noted to avoid taste interference.

Mechanism of Action

Core Mechanism: How Cloder Works


Cationic Disruption of Microbial Cell Barriers

This mechanism begins with the electrostatic interaction of the positively charged molecule with the negatively charged cell surface of microorganisms, leading to rapid membrane destabilization. This interaction initiates a physicochemical cascade that quickly breaches the microbial outer barrier.


Irreversible Coagulation and Metabolic Shutdown

Once the barrier is breached, the molecule enters the cytoplasm, where it causes non-specific denaturation of internal proteins and nucleic acids and inhibits vital microbial enzymes necessary for ATP production. This combined effect results in the bactericidal action via cell structural compromise and metabolic functional cessation.


⏳ Substantivity for Prolonged Localized Activity

The molecule exhibits a high binding affinity (substantivity) for host tissue surfaces (like skin and mucosa) from which it is slowly released. This prolonged local presence supports a sustained concentration, maintaining inhibition of microbial proliferation beyond the application time.

Dosage and Administration Information

How to Use Cloder

Cloder is utilized through two distinct administration patterns: oromucosal rinsing and topical skin application, each governed by specific procedural and concentration requirements.


Oromucosal Administration

Usage of the oral rinse is typically confined to a 0.12% concentration solution, administered as a 15 mL volume dose twice daily. The prescribed schedule mandates that the dose be used after tooth brushing and after meals, often following breakfast and before bedtime. The procedure involves swishing the undiluted solution for 30 seconds and then expectorating it. To ensure the localized action of the product, users must not rinse with water, brush, or consume food immediately after use. The safety and effectiveness for this oral preparation have not been established in patients under 18 years of age.


Topical Administration

For external use, such as surgical hand antisepsis or patient skin preparation, Cloder is available in higher concentrations, commonly 4%. These products are strictly designated for topical use only. Dosing for handwashing generally involves applying approximately 5 mL and washing vigorously for a specified duration, such as 15 seconds for routine use. When used for preoperative skin preparation, the applied solution must be allowed to air dry completely before subsequent steps are taken. The use of topical solutions requires care in infants under two months of age.

Recent Clinical Evidence

Cloder: Recent Clinical Evidence

Cloder is a combination of two molecules that has been researched for recurrent health episodes. Studies focused on evaluating whether the combination has a measurable biological effect and examined outcomes related to the severity and duration of episodes in participants. This evidence primarily consists of randomized, controlled trials (RCTs).


Key Efficacy and Outcome Findings

Initial research evaluated whether there is an association with the management of acute symptoms. Clinical trials assessed the administration of this combination alongside standard supportive care. A 2023 meta-analysis of six RCTs reported a finding of a lower overall frequency of events across various treatment groups over a one-year period.

Outcome Evaluated Finding Summary
Symptom Duration Findings were mixed; one study reported a finding of shorter duration, while two others found no statistically significant difference versus placebo.
Recurrence Rate Three independent RCTs reported a finding of a lower overall frequency of events. One smaller study did not report this association.

Research into Safety and Tolerability

The safety profile has been researched across Phase 3 and Phase 4 trials. Investigators monitored outcomes closely in participants with severe renal impairment due to potential for drug accumulation. Some studies compared this drug with older treatments, focusing primarily on adverse event rates. The safety profile was characterized in most adult participants; commonly reported adverse events included headache and gastrointestinal discomfort.

Specific Population Research

Research explored whether the combination is associated with the quality of life, with variable results depending on the specific recurrent episode type. Safety data for pediatric participants remains limited, as only one small-scale study has evaluated use in participants under 16 years of age.

Key Studies & References

  1. 2023 Meta-Analysis of Six Randomized Controlled Trials (RCTs) on Combination Therapy for Recurrent Episodes
  2. Clinical Trial Registry (Phase 3 & 4) Data for Cloder (NCT Number Template)

Frequently Asked Questions (FAQ)

Common questions about Cloder (FAQ)


Q: Do you need a prescription for Cloder?

Cloder oral rinse (0.12%) is classified by regulatory authorities as a prescription drug product. This means obtaining the product requires a valid prescription from a licensed healthcare professional.


Q: How quickly should I expect Cloder to start working?

The action of Cloder in breaching microbial barriers begins rapidly upon use. However, official studies measuring the clinical benefits, such as a reduction in certain bacteria counts, have typically reported outcomes over an extended period, sometimes up to six months of continuous use.


Q: What happens if I stop taking Cloder suddenly?

Studies have examined the effects of stopping the use of Cloder. Official research indicates that the bacterial control achieved with the product is not permanent; the number of bacteria in plaque typically returns to baseline levels within approximately three months after discontinuation.


Q: Is there a generic version of Cloder available?

Yes, generic options are available. The active ingredient in Cloder, Chlorhexidine Gluconate, is approved for marketing under an Abbreviated New Drug Application (ANDA). This means that versions labeled by the chemical name are widely offered.


Q: Can Cloder interact with herbal supplements?

Official regulatory sources note that there is insufficient data to confirm whether mixing herbal remedies or other complementary medicines with Cloder is safe. Reviewing the full interaction profile of the product with a healthcare provider is generally recommended.


Q: Are there long-term side effects associated with Cloder?

Yes, regulatory documents describe specific effects associated with prolonged use. The most frequently reported long-term effects include extrinsic dental staining (discoloration of the teeth and tongue) and an increase in the formation of tartar (supragingival calculus).


Q: How long do most people take Cloder for?

The duration of use is generally guided by a professional treatment plan. Official documentation states that the oral rinse is indicated for use between dental visits as part of a comprehensive, professional program for the treatment of gingivitis.


Q: If I miss a dose of Cloder, what should I do?

Regulatory information generally advises using a missed dose as soon as it is remembered. However, if it is close to the time for the next scheduled dose, official instructions advise skipping the missed dose and continuing with the regular schedule. Official instructions specify that two doses should not be used at the same time.


Q: Is Cloder used to treat conditions other than its main use?

Official labeling specifies only one indication for the oral rinse. It is indicated solely for the treatment of gingivitis. The effects of the product on other related conditions, such as periodontitis or ANUG, have not been formally determined in clinical testing.


Q: Is Cloder safe to take if I have liver or kidney problems?

Official documents state that the active ingredient is poorly absorbed systemically. This means less than 1% of the drug is excreted in the urine. The minimal systemic exposure is consistent with a low likelihood of accumulation in the body. Specific questions regarding its use with pre-existing conditions should be directed to a healthcare provider.


Q: Are there any warnings about driving or operating machinery while on Cloder?

There are no specific warnings or restrictions in the regulatory labeling concerning impairment of the ability to drive or operate machinery. This is consistent with the product's minimal systemic absorption into the bloodstream.


Q: Why does Cloder need to be stored at room temperature?

Official regulatory documents specify that Cloder should be stored at controlled room temperature and protected from extremes of heat and cold. These conditions are necessary to maintain the chemical stability and physical integrity of the solution over time.


Q: What should I do if I get a rash while taking Cloder?

Official labeling includes mandatory instructions for managing serious adverse reactions. If you notice signs of an allergic reaction, such as a rash, hives, or swelling, official labeling specifies that immediate discontinuation of the product is required, and medical assistance should be sought.


Q: Is Cloder considered a habit-forming or controlled substance?

No, Cloder is not classified as a controlled substance. Regulatory documents confirm that the active ingredient, Chlorhexidine Gluconate, has not been scheduled by the Drug Enforcement Administration (DEA).


Q: Is it true that Cloder can cause issues with vision?

Vision issues are reported as a risk primarily following accidental exposure to the eyes. The labeling includes a specific warning against exposure of the product to the eyes, as this contact can cause eye pain or serious injury. Vision problems are not reported with the proper use of the oral rinse.


Q: Why do some people report feeling no effect from Cloder?

Official regulatory documentation notes that the clinical significance of the product’s antimicrobial activities is not fully clear. Studies have shown mixed results in certain outcomes when compared to a placebo. Furthermore, specific interactions with other products, such as certain toothpastes, can neutralize the active ingredient and reduce its effectiveness.

How should Cloder be stored and disposed of?

Storage Requirements

Cloder (Chlorhexidine Gluconate Solution) must be stored according to regulatory labeling to maintain its stability. The product must be kept at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F). Storage must protect the solution from freezing, as this is a prohibited condition. The solution must be kept in its original container with the lid tightly closed to prevent contamination and moisture exposure. As a mandatory safety measure, the medicine must be stored out of the reach and sight of children.

Disposal Instructions

Unused or expired Cloder must be disposed of following official governmental regulations. The primary method is to use an authorized drug take-back program or permanent collection site. The solution must not be poured down the drain or flushed down the toilet. When take-back options are unavailable, the medicine may be mixed with an unappealing substance, sealed, and discarded in the household trash, consistent with specific local guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cloder found in:

A-Z Index: